{
  "retracted": false,
  "timestamp": 1579651200000,
  "updates": [
    {
      "timestamp": 1591731405040,
      "identifier": {
        "doi": "10.1007/s10157-020-01845-4"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s10157-019-01811-9"
  },
  "journal": "Clinical and Experimental Nephrology",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: Dotinurad: a novel selective urate reabsorption inhibitor as a future therapeutic option for hyperuricemia"
}
